BioAdaptives Welcomes UFC Senior Executive Reed Harris to Its Board of Advisors
BioAdaptives Inc. (OTC: BDPT) has appointed Reed Harris to its Board of Advisors. Harris, currently serving as Senior Vice President of Athlete Development and Marketing at UFC, brings over 40 years of experience in leadership and business management. He is the founder of World Extreme Cagefighting (WEC), which he sold to UFC in 2006 and managed until its 2012 merger.
Harris will collaborate with BioAdaptives' marketing department to launch several new products, including Xcellera, a stem cell activator. Clinical trials have shown Xcellera increases circulating stem cells by 268.8% in 28 days, supporting tissue repair, anti-aging, immune and cardiovascular functions.
BioAdaptives Inc. (OTC: BDPT) ha nominato Reed Harris nel suo Consiglio di Amministrazione. Harris, attualmente Senior Vice President dello Sviluppo degli Atleti e Marketing presso UFC, porta con sé oltre 40 anni di esperienza nella leadership e gestione aziendale. È il fondatore del World Extreme Cagefighting (WEC), che ha venduto a UFC nel 2006 e ha gestito fino alla fusione nel 2012.
Harris collaborerà con il dipartimento marketing di BioAdaptives per lanciare diversi nuovi prodotti, tra cui Xcellera, un attivatore di cellule staminali. Le prove cliniche hanno dimostrato che Xcellera aumenta le cellule staminali circolanti del 268,8% in 28 giorni, supportando la riparazione dei tessuti, l'anti-invecchiamento, le funzioni immunitarie e cardiovascolari.
BioAdaptives Inc. (OTC: BDPT) ha nombrado a Reed Harris en su Junta Asesora. Harris, que actualmente se desempeña como Vicepresidente Senior de Desarrollo de Atletas y Marketing en UFC, aporta más de 40 años de experiencia en liderazgo y gestión empresarial. Es el fundador de World Extreme Cagefighting (WEC), que vendió a UFC en 2006 y gestionó hasta su fusión en 2012.
Harris colaborará con el departamento de marketing de BioAdaptives para lanzar varios productos nuevos, incluido Xcellera, un activador de células madre. Los ensayos clínicos han demostrado que Xcellera aumenta las células madre circulantes en un 268,8% en 28 días, apoyando la reparación de tejidos, el anti-envejecimiento, las funciones inmunitarias y cardiovasculares.
BioAdaptives Inc. (OTC: BDPT)는 Reed Harris를 고문단에 임명했습니다. Harris는 현재 UFC에서 선수 개발 및 마케팅의 수석 부사장을 맡고 있으며, 40년 이상의 리더십 및 비즈니스 관리 경험을 가지고 있습니다. 그는 2006년에 UFC에 판매하고 2012년 합병까지 관리했던 World Extreme Cagefighting (WEC)의 창립자입니다.
Harris는 BioAdaptives의 마케팅 부서와 협력하여 Xcellera를 포함한 여러 신제품을 출시할 예정입니다. 임상 시험에 따르면 Xcellera는 28일 동안 순환하는 줄기세포를 268.8% 증가시켜 조직 복구, 노화 방지, 면역 및 심혈관 기능을 지원합니다.
BioAdaptives Inc. (OTC: BDPT) a nommé Reed Harris dans son Conseil d'Consultation. Harris, actuellement Vice-Président Senior du Développement des Athlètes et du Marketing chez UFC, apporte plus de 40 ans d'expérience en leadership et en gestion d'entreprise. Il est le fondateur de World Extreme Cagefighting (WEC), qu'il a vendu à UFC en 2006 et qu'il a dirigé jusqu'à sa fusion en 2012.
Harris collaborera avec le département marketing de BioAdaptives pour lancer plusieurs nouveaux produits, dont Xcellera, un activateur de cellules souches. Des essais cliniques ont montré qu'Xcellera augmente les cellules souches circulantes de 268,8 % en 28 jours, soutenant la réparation des tissus, l'anti-âge, ainsi que les fonctions immunitaires et cardiovasculaires.
BioAdaptives Inc. (OTC: BDPT) hat Reed Harris in seinen Beirat berufen. Harris, der derzeit als Senior Vice President für Athletenentwicklung und Marketing bei der UFC tätig ist, bringt über 40 Jahre Erfahrung in Führung und Unternehmensmanagement mit. Er ist der Gründer von World Extreme Cagefighting (WEC), das er 2006 an die UFC verkaufte und bis zur Fusion im Jahr 2012 leitete.
Harris wird mit der Marketingabteilung von BioAdaptives zusammenarbeiten, um mehrere neue Produkte einzuführen, darunter Xcellera, einen Aktivator für Stammzellen. Klinische Studien haben gezeigt, dass Xcellera die zirkulierenden Stammzellen innerhalb von 28 Tagen um 268,8 % erhöht, was die Gewebereparatur, Anti-Aging sowie Immun- und kardiovaskuläre Funktionen unterstützt.
- Clinical trial data shows Xcellera increases circulating stem cells by 268.8% in 28 days
- Strategic appointment of UFC Senior Executive adds expertise in marketing and business development
- None.
Harris, the Senior Vice President of Athlete Development and Marketing at the Ultimate Fighting Championship, has a distinguished career spanning over 40 years
LAS VEGAS, Feb. 06, 2025 (GLOBE NEWSWIRE) -- via IBN – BioAdaptives Inc. (OTC: BDPT), a leading biotechnology company focused on innovative health and wellness solutions, proudly announces the appointment of Reed Harris to its Board of Advisors. Harris brings decades of experience in leadership, athlete development and business management, and an unparalleled commitment to innovation and excellence in professional and personal endeavors.
Reed Harris, the Senior Vice President of Athlete Development and Marketing at the Ultimate Fighting Championship (UFC) in Las Vegas, has a distinguished career spanning over 40 years. He blends expertise in martial arts, business development and charity work. His life and career reflect a dedication to discipline, growth and giving back to the community.
Harris founded World Extreme Cagefighting (WEC), one of the leading MMA promotions in the U.S. and internationally broadcasted in Canada, Brazil, Mexico and Australia. He sold WEC to the UFC in 2006 and continued to run the organization until its merger with the UFC in 2012.
Harris will work closely with BioAdaptives' marketing department to introduce several new products, including Xcellera, the stem cell activator proven in randomized, double-blind, placebo-controlled human clinical trials to increase circulating stem cells on average by
Jim Keener, CEO of BioAdaptives, Inc., said: "We are excited to welcome Reed Harris to our Board of Advisors. Reed’s exceptional leadership, business acumen and dedication to athlete development and community service align perfectly with our mission to deliver innovative health and wellness solutions. His deep experience building and managing successful organizations and his passion for helping others makes him an invaluable asset to BioAdaptives as we expand our reach and impact."
Reed Harris’s addition to the Board of Advisors reflects BioAdaptives’ commitment to strengthening its leadership team and advancing its mission of improving lives through cutting-edge biotechnology and holistic health solutions.
About BioAdaptives, Inc.
BioAdaptives, Inc. (OTC: BDPT) is a leading innovator in the health and wellness industry, dedicated to developing and marketing nutraceutical and wellness products that harness the power of natural ingredients and cutting-edge science. Our mission is to improve the quality of life for our customers by offering products that support optimal health and vitality.
For more information about Xcellara™ Stem Cell Activator and other BioAdaptives products, please visit our website at www.bioadaptives.com.
Contact Information:
BioAdaptives, Inc.
Emily Harrison
IR Coordinator
(702)-659-8829
info@bioadaptives.com
2620 Regatta Dr, Suite 102
Las Vegas, NV 89128
Forward-Looking Statements: This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, among other things, statements regarding expected growth, potential benefits of the company's products, and future business opportunities. These statements involve risks, uncertainties, and other factors that may cause actual results or developments to differ materially from those expressed or implied.
Wire Service Contact:
IBN
Austin, Texas
www.InvestorBrandNetwork.com
512.354.7000 Office
Editor@InvestorBrandNetwork.com
FAQ
What is BioAdaptives' (BDPTD) new stem cell activator product and its effectiveness?
Who is the new Board of Advisors member for BioAdaptives (BDPTD) and what is his background?
What role will Reed Harris play in BioAdaptives (BDPTD)?
When did BioAdaptives (BDPTD) announce the appointment of Reed Harris?
